Berezowsky Alexandra, Ardestani Shakiba, Hiersch Liran, Shah Baiju R, Berger Howard, Halperin Ilana, Retnakaran Ravi, Barrett Jon, Melamed Nir
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynaecology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.
Lis Maternity Hospital, Tel Aviv Sourasky Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Am J Obstet Gynecol. 2023 Dec;229(6):682.e1-682.e13. doi: 10.1016/j.ajog.2023.06.046. Epub 2023 Jun 29.
Preliminary data suggest that strict glycemic control in twin pregnancies with gestational diabetes mellitus may not improve outcomes but might increase the risk of fetal growth restriction.
This study aimed to investigate the association of maternal glycemic control with the risk of gestational diabetes mellitus-related complications and small for gestational age in twin pregnancies complicated by gestational diabetes mellitus.
This was a retrospective cohort study of all patients with a twin pregnancy complicated by gestational diabetes mellitus in a single tertiary center between 2011 and 2020, and a matched control group of patients with a twin pregnancy without gestational diabetes mellitus in a 1:3 ratio. The exposure was the level of glycemic control, described as the proportion of fasting, postprandial, and overall glucose values within target. Good glycemic control was defined as a proportion of values within target above the 50th percentile. The first coprimary outcome was a composite variable of neonatal morbidity, defined as at least 1 of the following: birthweight >90th centile for gestational age, hypoglycemia requiring treatment, jaundice requiring phototherapy, birth trauma, or admission to the neonatal intensive care unit at term. A second coprimary outcome was small for gestational age, defined as birthweight <10th centile or <3rd centile for gestational age. Associations between the level of glycemic control and the study outcomes were estimated using logistic regression analysis and were expressed as adjusted odds ratio with 95% confidence interval.
A total of 105 patients with gestational diabetes mellitus in a twin pregnancy met the study criteria. The overall rate of the primary outcome was 32.4% (34/105), and the overall proportion of pregnancies with a small for gestational age newborn at birth was 43.8% (46/105). Good glycemic control was not associated with a reduction in the risk of composite neonatal morbidity when compared with suboptimal glycemic control (32.1% vs 32.7%; adjusted odds ratio, 2.06 [95% confidence interval, 0.77-5.49]). However, good glycemic control was associated with higher odds of small for gestational age compared with nongestational diabetes mellitus pregnancies, especially in the subgroup of diet-treated gestational diabetes mellitus (65.5% vs 34.0%, respectively; adjusted odds ratio, 4.17 [95% confidence interval, 1.74-10.01] for small for gestational age <10th centile; and 24.1% vs 7.0%, respectively; adjusted odds ratio, 3.97 [95% confidence interval, 1.42-11.10] for small for gestational age <3rd centile). In contrast, the rate of small for gestational age in gestational diabetes mellitus pregnancies with suboptimal control was not considerably different when compared with non-gestational diabetes mellitus pregnancies. In addition, in cases of diet-treated gestational diabetes mellitus, good glycemic control was associated with a left-shift of the distribution of birthweight centiles, whereas the distribution of birthweight centiles among gestational diabetes mellitus pregnancies with suboptimal control was similar to that of nongestational diabetes mellitus pregnancies.
In patients with gestational diabetes mellitus in a twin pregnancy, good glycemic control is not associated with a reduction in the risk of gestational diabetes mellitus-related complications but may increase the risk of a small for gestational age newborn in the subgroup of patients with mild (diet-treated) gestational diabetes mellitus. These findings further question whether the gestational diabetes mellitus glycemic targets used in singleton pregnancies also apply to twin pregnancies and support the concern that applying the same diagnostic criteria and glycemic targets in twin pregnancies may result in overdiagnosis and overtreatment of gestational diabetes mellitus and potential neonatal harm.
初步数据表明,妊娠期糖尿病双胎妊娠患者进行严格血糖控制可能无法改善结局,反而可能增加胎儿生长受限的风险。
本研究旨在探讨妊娠期糖尿病双胎妊娠患者的母体血糖控制与妊娠期糖尿病相关并发症及小于胎龄儿风险之间的关联。
这是一项回顾性队列研究,研究对象为2011年至2020年期间在单一三级中心确诊为妊娠期糖尿病的所有双胎妊娠患者,以及按1:3比例匹配的无妊娠期糖尿病的双胎妊娠患者对照组。暴露因素为血糖控制水平,以空腹、餐后及总体血糖值在目标范围内的比例来描述。良好的血糖控制定义为目标范围内的值的比例高于第50百分位数。第一个共同主要结局是新生儿发病率的复合变量,定义为以下至少一项:出生体重>胎龄第90百分位数、需要治疗的低血糖、需要光疗的黄疸、出生创伤或足月时入住新生儿重症监护病房。第二个共同主要结局是小于胎龄儿,定义为出生体重<胎龄第10百分位数或<第3百分位数。使用逻辑回归分析估计血糖控制水平与研究结局之间的关联,并以调整后的优势比及95%置信区间表示。
共有105例妊娠期糖尿病双胎妊娠患者符合研究标准。主要结局的总体发生率为32.4%(34/105),出生时新生儿为小于胎龄儿的妊娠总体比例为43.8%(46/105)。与血糖控制欠佳相比,良好的血糖控制与复合新生儿发病率风险降低无关(32.1%对32.7%;调整后的优势比为2.06[95%置信区间为0.77 - 5.49])。然而,与非妊娠期糖尿病妊娠相比,良好的血糖控制与小于胎龄儿的较高几率相关,尤其是在饮食治疗的妊娠期糖尿病亚组中(分别为65.5%对34.0%;小于胎龄儿<第10百分位数时调整后的优势比为4.17[95%置信区间为1.74 - 10.01];分别为24.1%对7.0%;小于胎龄儿<第3百分位数时调整后的优势比为3.97[95%置信区间为1.42 - 11.10])。相比之下,血糖控制欠佳的妊娠期糖尿病妊娠中小于胎龄儿的发生率与非妊娠期糖尿病妊娠相比无显著差异。此外,在饮食治疗的妊娠期糖尿病病例中,良好的血糖控制与出生体重百分位数分布左移相关,而血糖控制欠佳的妊娠期糖尿病妊娠中出生体重百分位数分布与非妊娠期糖尿病妊娠相似。
在妊娠期糖尿病双胎妊娠患者中,良好的血糖控制与妊娠期糖尿病相关并发症风险降低无关,但可能增加轻度(饮食治疗)妊娠期糖尿病患者亚组中小于胎龄儿新生儿的风险。这些发现进一步质疑了单胎妊娠中使用的妊娠期糖尿病血糖目标是否也适用于双胎妊娠,并支持了这样一种担忧,即在双胎妊娠中应用相同的诊断标准和血糖目标可能导致妊娠期糖尿病的过度诊断和过度治疗以及潜在的新生儿伤害。